Global Clinical Trial Packaging Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Clinical Trial Packaging Market Research Report 2024
The global clinical trial packaging market has witnessed impressive growth in the past decade, due to growing pharmaceutical packaging products trade across the globe. The demand of clinical trial packaging has witnessed an upstick in the recent past.
According to MRAResearch’s new survey, global Clinical Trial Packaging market is projected to reach US$ 1354 million in 2033, increasing from US$ 927 million in 2022, with the CAGR of 5.1% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Clinical Trial Packaging market research.
Key companies engaged in the Clinical Trial Packaging industry include Bilcare, Fisher Clinical Services, WuXi AppTec, PCI Pharma Services, Almac Group, PharMaterials, PAREXEL, Schreiner MediPharm and Sharp Packaging, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Clinical Trial Packaging were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Clinical Trial Packaging market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Clinical Trial Packaging market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Bilcare
Fisher Clinical Services
WuXi AppTec
PCI Pharma Services
Almac Group
PharMaterials
PAREXEL
Schreiner MediPharm
Sharp Packaging
The Coghlan Group
Rubicon
Westrock
Xerimis
Catalent
Piramal Pharma Solutions
Corden Pharma
DMB Consultancy
Körber Medipak Systems
Sentry BioPharma
NextPharma
Mawdsleys
Segment by Type
Syringes
Vials and Ampoules
Blisters
Tubes
Bottles
Bags and Pouches
Sachets
Kits or Packs
Others
Drug Manufacturing Companies
Research Laboratories
Clinical Research Organizations
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Clinical Trial Packaging report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global Clinical Trial Packaging market is projected to reach US$ 1354 million in 2033, increasing from US$ 927 million in 2022, with the CAGR of 5.1% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Clinical Trial Packaging market research.
Key companies engaged in the Clinical Trial Packaging industry include Bilcare, Fisher Clinical Services, WuXi AppTec, PCI Pharma Services, Almac Group, PharMaterials, PAREXEL, Schreiner MediPharm and Sharp Packaging, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Clinical Trial Packaging were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Clinical Trial Packaging market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Clinical Trial Packaging market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Bilcare
Fisher Clinical Services
WuXi AppTec
PCI Pharma Services
Almac Group
PharMaterials
PAREXEL
Schreiner MediPharm
Sharp Packaging
The Coghlan Group
Rubicon
Westrock
Xerimis
Catalent
Piramal Pharma Solutions
Corden Pharma
DMB Consultancy
Körber Medipak Systems
Sentry BioPharma
NextPharma
Mawdsleys
Segment by Type
Syringes
Vials and Ampoules
Blisters
Tubes
Bottles
Bags and Pouches
Sachets
Kits or Packs
Others
Segment by Application
Drug Manufacturing Companies
Research Laboratories
Clinical Research Organizations
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Clinical Trial Packaging report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source